Market Currents
Shares of Arena Pharmaceutical (ARNA +1.8%) and Vivus (VVUS +3.3%) both gain today, after...
-
Wednesday, February 6, 12:20 PM ETShares of Arena Pharmaceutical (ARNA +1.8%) and Vivus (VVUS +3.3%) both gain today, after Leerink Swann resumes coverage on both with an Outperform rating. The firm gives VVUS a price target range of $19 - $20.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
This news story has 2 comments:
Can't wait for the EMA's decision on Belviq. I hope it'll shut some of you guys up a bit, but I know you'll just cling to a new fallacy.